Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Probably...but we will see
If $17 holds I'll buy a bit more. Currently only holding 1k...I'll buy 250 more if 17 holds...otherwise I'll look to buy a lot more in the coming weeks.
Support around $12...let's see if shorts can walk it down
I have a bit of holdings now...waiting a bit after the Taiwan play before buying a lot more. So maybe OCT.
Notably other Cepi recipients are NVAX, MRNA...any type of good news will send this one
How high do we go
CEPI recipient...this will be a major run
Dynavax Technologies (DVAX)
13.18 ? 0.4 (3.13%)
Volume: 5,264,064 @08/13/21 7:59:44 PM EDT
Bid Ask Day's Range
13.15 13.18 12.79 - 13.87
DVAX Detailed Quote
Dynavax Technologies (DVAX)
9.41 ? 0.16 (1.73%)
Volume: 993,606 @07/09/21 7:55:26 PM EDT
Bid Ask Day's Range
9.47 11.0 9.06 - 9.49
DVAX Detailed Quote
Dynavax Technologies (DVAX)
7.71 ? 0.08 (1.05%)
Volume: 410,984 @05/26/21 11:38:09 AM EDT
Bid Ask Day's Range
7.71 7.72 7.62 - 7.785
DVAX Detailed Quote
Dynavax Technologies (DVAX)
11.04 ? 0.18 (1.66%)
Volume: 2,400,722 @04/16/21 7:58:28 PM EDT
Bid Ask Day's Range
11.04 12.78 10.6004 - 11.2
DVAX Detailed Quote
1D
Dynavax Technologies (DVAX)
10.15 ? 0.63 (6.62%)
Volume: 8,668,532 @02/19/21 7:59:59 PM EST
Bid Ask Day's Range
10.11 10.15 9.52 - 11.0
DVAX Detailed Quote
Dynavax Technologies Receives European Marketing Approval for Hepatitis B Vaccine; Shares Rise Midday
1:08 PM ET, 02/19/2021 - MT Newswires
01:08 PM EST, 02/19/2021 (MT Newswires) -- Dynavax Technologies (DVAX) said the European Commission has granted marketing authorization for Heplisav-B, the biopharmaceutical company's vaccine for hepatitis B in adults 18 and older.
The approval follows a positive opinion from the European Medicines Agency on Dynavax's marketing authorization application, which was based on safety and immunogenicity results from three phase 3 clinical trials. European Commission marketing authorization approval is valid in all EU countries and Norway, Iceland, and Liechtenstein.
Shares of Dynavax are up more than 5% in midday trading.
BIG BIG BIG GAINER Dynavax Technologies (DVAX)
10.45 ? 4.14 (65.61%)
Volume: 107,086,749 @02/01/21 6:46:50 PM EST
Bid Ask Day's Range
10.4 10.45 7.06 - 11.69
DVAX Detailed Quote
* * $DVAX Video Chart 02-01-2021 * *
Link to Video - click here to watch the technical chart video
Been sitting on this a long time. Patience Pays !!
$DVAX Technical Analysis
http://www.stockta.com/cgi-bin/analysis.pl?symb=DVAX&cobrand=&mode=stock
Dynavax Technologies (DVAX)
5.21 ? 0.04 (0.77%)
Volume: 4,482 @12/15/20 9:05:24 AM EST
Bid Ask Day's Range
5.22 5.24 - - -
DVAX Detailed Quote
Dynavax Technologies (DVAX)
4.885 ? -0.275 (-5.33%)
Volume: 1,790,117 @12/07/20 12:48:32 PM EST
Bid Ask Day's Range
4.88 4.89 4.79 - 5.1
DVAX Detailed Quote
Dynavax Technologies (DVAX)
4.885 ? -0.275 (-5.33%)
Volume: 1,790,117 @12/07/20 12:48:32 PM EST
Bid Ask Day's Range
4.88 4.89 4.79 - 5.1
DVAX Detailed Quote
Dynavax Technologies (DVAX)
4.19 ? -0.01 (-0.24%)
Volume: 2,001,570 @11/24/20 7:57:20 PM EST
Bid Ask Day's Range
4.19 4.22 4.06 - 4.28
DVAX Detailed Quote
Dynavax Technologies (DVAX)
4.18 ? -0.02 (-0.48%)
Volume: 2,083,697 @10/23/20 7:58:23 PM EDT
Bid Ask Day's Range
4.0 4.4 4.07 - 4.25
DVAX Detailed Quote
BREAKING NEWS: $DVAX Medigen's COVID-19 Vaccine Combined with Dynavax's CpG 1018 Adjuvant Receives Taiwan Government Subsidy with First Participant Dosed in Early October
Medigen's COVID-19 Vaccine Combined with Dynavax's CpG 1018 Adjuvant Receives Taiwan Government Subsidy with First Participant Dosed in Early October PR Newswire TAPEI, Taiwan and EMERYVILLE, Calif., Oct. 13, 2020 TAPEI, Taiwan and EMERYVILLE, Calif. , Oct....
Find out more DVAX - Medigen's COVID-19 Vaccine Combined with Dynavax's CpG 1018 Adjuvant Receives Taiwan Government Subsidy with First Participant Dosed in Early October
Dynavax Technologies (DVAX)
4.37 ? -0.16 (-3.53%)
Volume: 3,904,787 @09/24/20 7:59:11 PM EDT
Bid Ask Day's Range
4.37 4.41 4.22 - 4.53
DVAX Detailed Quote
Dynavax Technologies (DVAX)
4.37 ? -0.16 (-3.53%)
Volume: 3,904,787 @09/24/20 7:59:11 PM EDT
Bid Ask Day's Range
4.37 4.41 4.22 - 4.53
DVAX Detailed Quote
* * $DVAX Video Chart 09-14-2020 * *
Link to Video - click here to watch the technical chart video
Dynavax Technologies (DVAX)
4.91 ? -0.38 (-7.18%)
Volume: 4,927,534 @09/04/20 7:59:32 PM EDT
Bid Ask Day's Range
4.55 5.0 4.52 - 5.31
DVAX Detailed Quote
Major support @ 10? Lol this is at $6 right now! Maybe you meant another stock.
DVAX here needs to stay above the weekly 20 MA for a setup next week. Currently $6.40. GLTU
Major support at 10. Time to get in
Hmmm... interesting charts. Watching, waiting, ready. GLTA
Dynavax Technologies (DVAX)
6.75 ? -0.06 (-0.88%)
Volume: 3,394,043 @08/14/20 7:58:28 PM EDT
Bid Ask Day's Range
5.77 7.28 6.53 - 7.0
DVAX Detailed Quote
Dynavax Technologies (DVAX)
8.88 ? -1.24 (-12.25%)
Volume: 7,274,183 @07/24/20 7:59:49 PM EDT
Bid Ask Day's Range
9.03 9.05 8.8 - 9.86
DVAX Detailed Quote
Followers
|
108
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
2538
|
Created
|
10/09/06
|
Type
|
Free
|
Moderators |
We are developing cutting-edge vaccines by utilizing our innovative adjuvant technology and our expertise of Toll-like Receptor (TLR) biology to modulate the immune system.
HEPLISAV-B®
[HEPATITIS B VACCINE (RECOMBINANT) ADJUVANTED]
During the uncertainty caused by the COVID-19 pandemic, Dynavax has acted quickly to focus on four key areas
– these include safeguarding the health and safety of our employees and customers; continuing effective operations
to ensure patient access to HEPLISAV-B® [Hepatitis B Vaccine (Recombinant), Adjuvanted]; maintaining our financial strength and stability;
and supporting efforts to develop a COVID-19 vaccine.
Shs Outstand | 85.48M |
Shs Float | 84.14M |
Short Float | 18.11% |
Debt/Eq | 15.22 |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |